Immutep receives A$856,669 R&D tax rebate from Australia
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Immtech Pharmaceuticals, Inc. (NASDAQ: IMMP) | Delayed: 3.20 +0.03 (0.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.17 | 52 Week High | $0.01 | |||
| Open | $3.21 | 52 Week Low | $0.00 | |||
| Day High | $3.23 | P/E | N/A | |||
| Day Low | $3.10 | EPS | $0.00 | |||
| Volume | 7,943 | |||||
